David Windley
Stock Analyst at Jefferies
(3.54)
# 854
Out of 5,149 analysts
204
Total ratings
65.55%
Success rate
13.14%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Upgrades: Buy | $175 → $135 | $108.70 | +24.20% | 16 | Feb 23, 2026 | |
| MEDP Medpace Holdings | Upgrades: Buy | $560 | $465.38 | +20.33% | 7 | Feb 13, 2026 | |
| HUM Humana | Maintains: Buy | $310 → $235 | $181.58 | +29.42% | 20 | Feb 12, 2026 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $255 | $173.96 | +46.59% | 6 | Feb 6, 2026 | |
| UNH UnitedHealth Group | Maintains: Buy | $418 → $340 | $289.21 | +17.56% | 28 | Jan 28, 2026 | |
| DEO Diageo | Downgrades: Neutral | n/a | $84.12 | - | 1 | Dec 3, 2025 | |
| FTRE Fortrea Holdings | Maintains: Hold | $7 → $9.5 | $10.48 | -9.35% | 3 | Sep 9, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $142 → $195 | $175.69 | +10.99% | 20 | Sep 9, 2025 | |
| STE STERIS | Initiates: Hold | $263 | $243.35 | +8.07% | 1 | May 29, 2025 | |
| SLQT SelectQuote | Initiates: Hold | $2.75 | $0.79 | +249.87% | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $64 → $61 | $43.82 | +39.21% | 28 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $12 | $13.67 | -12.22% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $402 → $422 | $283.93 | +48.63% | 17 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $297 | $144.81 | +105.10% | 23 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $0.28 | +1,219.03% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $284.03 | +112.65% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $497.42 | -24.61% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $15.70 | -1.27% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $185.91 | +45.23% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $7.24 | +114.09% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $251.38 | +113.22% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $14.73 | +96.88% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $5.10 | +4,762.75% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $0.83 | - | 5 | Oct 9, 2017 |
ICON Public Limited Company
Feb 23, 2026
Upgrades: Buy
Price Target: $175 → $135
Current: $108.70
Upside: +24.20%
Medpace Holdings
Feb 13, 2026
Upgrades: Buy
Price Target: $560
Current: $465.38
Upside: +20.33%
Humana
Feb 12, 2026
Maintains: Buy
Price Target: $310 → $235
Current: $181.58
Upside: +29.42%
IQVIA Holdings
Feb 6, 2026
Maintains: Buy
Price Target: $270 → $255
Current: $173.96
Upside: +46.59%
UnitedHealth Group
Jan 28, 2026
Maintains: Buy
Price Target: $418 → $340
Current: $289.21
Upside: +17.56%
Diageo
Dec 3, 2025
Downgrades: Neutral
Price Target: n/a
Current: $84.12
Upside: -
Fortrea Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $7 → $9.5
Current: $10.48
Upside: -9.35%
Charles River Laboratories International
Sep 9, 2025
Upgrades: Buy
Price Target: $142 → $195
Current: $175.69
Upside: +10.99%
STERIS
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $243.35
Upside: +8.07%
SelectQuote
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $0.79
Upside: +249.87%
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $43.82
Upside: +39.21%
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $13.67
Upside: -12.22%
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $283.93
Upside: +48.63%
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $144.81
Upside: +105.10%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $0.28
Upside: +1,219.03%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $284.03
Upside: +112.65%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $497.42
Upside: -24.61%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $15.70
Upside: -1.27%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $185.91
Upside: +45.23%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $7.24
Upside: +114.09%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $251.38
Upside: +113.22%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $14.73
Upside: +96.88%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $5.10
Upside: +4,762.75%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $0.83
Upside: -